Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease characterized by increasing breathlessness. It's a major cause of morbidity and mortality globally, making it crucial for healthcare professionals to understand the nuances of its diagnosis and treatment.
Diagnosis of COPD involves a careful review of the patient's history, physical examination, and confirmation by spirometry. Spirometry measures the amount and speed of air a person can inhale and exhale, providing a critical tool in diagnosing COPD. An FEV1/FVC ratio less than 0.7 after bronchodilator use is indicative of COPD.
Management of COPD has evolved significantly over the years. Pharmacotherapy remains the mainstay of treatment, with bronchodilators being the cornerstone. Inhaled corticosteroids are added for patients with a history of exacerbations. Recently, the role of roflumilast and azithromycin in reducing exacerbations has been recognized.
Non-pharmacological therapies like pulmonary rehabilitation and oxygen therapy have a significant role in managing COPD. Pulmonary rehabilitation improves exercise capacity and quality of life, while long-term oxygen therapy is beneficial in patients with severe resting hypoxemia.
Research into novel treatments for COPD is ongoing. Triple therapy (ICS/LABA/LAMA) has shown promise in reducing exacerbations and improving lung function. Biological therapies targeting eosinophils and neutrophils are also under investigation. Lung volume reduction procedures and endobronchial valves offer new hope for selected patients.
COPD is a complex and challenging disease to manage. The key to effective management lies in accurate diagnosis and a personalized approach to treatment. Understanding the modern treatment approaches, including emerging therapies, is essential for healthcare professionals to improve patient outcomes. The future holds promise for more targeted and effective therapies for COPD.
1.
Combo Therapy Boosts Early CML Response but Not Long Term
2.
PNH With Extravascular Hemolysis Approves Factor D Inhibitor.
3.
In a long-term comparison with adjuvant RT, salvage radiotherapy after prostateectomy is the most successful treatment.
4.
AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns
5.
Classifying childhood brain cancers by immune response may improve diagnostics and treatments
1.
Precision Oncology: Integrating Genomics and Data to Shape Cancer Care’s Future
2.
Decoding Hamartomas: Understanding Their Causes and Symptoms
3.
Understanding the Silent Threat: Unveiling Prostate Cancer Symptoms
4.
Battling Blood Cancers: Advances in HIV-Related Hematologic Malignancies in the ART Era
5.
Breaking Barriers: Innovative Approaches in Brain Tumor Treatment
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Effect of Pablociclib in Endocrine Resistant Patients - A Panel Discussion
2.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Final Discussion
3.
Efficient Management of First line ALK-rearranged NSCLC
4.
Updates on Standard V/S High Risk Myeloma Treatment- The Next Part
5.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation